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Auditory verbal hallucinations (AVHs) are experienced by individuals with various clinical
diagnoses, such as psychosis, but also a significant minority of healthy individuals from
the general population may experience them. Although much research has been carried
out the past few decades, the mechanisms and factors underlying the emergence of
AVHs is still poorly understood. One way of clarifying this issue involves comparing AVHs
in patient and non-patient populations. In particular, differences between these groups
will provide important information concerning the emergence of AVHs. After a general
presentation and discussion of the notion of a continuum hypothesis, studies comparing
patients with non-patients experiencing AVHs will be reviewed. This will comprise studies
examining the phenomenological characteristics of AVHs in addition to neuroimaging
and cognitive studies. Although we are beginning to elucidate important differences
on a phenomenological level between these two types of AVHs, far too few studies
have directly compared patient and non-patient AVHs in terms of underlying cerebral
correlates and cognitive mechanisms. Nevertheless, and based on recent research on
phenomenological differences, two issues stand out that need to be addressed, namely,
the highly negative emotional content of AVHs in patients and the early onset of AVHs in
non-patients populations. Suggestions for future research will be discussed.
Keywords: hallucinations, auditory verbal hallucinations, voice-hearing, continuum, dimension, phenomenology,
cognition, neuroimaging
INTRODUCTION
Hallucinations, or perceptions in the absence of stimuli, may
occur in any sensory modality such as auditory, visual, olfac-
tory, gustatory, or tactile. They are very common in indi-
viduals with schizophrenia, but may also occur in those
suffering from various other psychopathological (e.g., mood
disorders, Post-traumatic Stress Disorder, Substance abuse,
Borderline Personality Disorder) or neurological (e.g., Dementia,
Parkinson’s disease, epilepsy) disorders. Studies have furthermore
shown that a significant minority of otherwise healthy persons
may also experience hallucinations (for reviews of this literature,
see Aleman and Larøi, 2008 and Beavan et al., 2011).
Auditory hallucinations represent a particularly rich and var-
ied phenomenology. They involve the perception of a large array
of sounds, which, when involving voices, are referred to as audi-
tory verbal hallucinations (AVHs). AVHs are the main focus of
the present article as this type of hallucination has been the most
often examined in the literature in general, but also in studies
comparing hallucinations in clinical groups compared to those
experienced by non-clinical or healthy persons.
Despite a significant increase in studies investigating AVHs
in the past few decades (cf. Aleman and Larøi, 2008), they
remain poorly understood, in particular regarding underlying
mechanisms and factors involved in the development or emer-
gence of AVHs. There exist a number of approaches that can
be adopted in order to better elucidate this process. One partic-
ularly fruitful recent approach to resolving this issue has been
the use of combined epidemiological and longitudinal studies
(i.e., following up a representative group of individuals from
the general population over time). This line of research can, for
example, investigate the nature of the transition from a non-
clinical hallucination to a clinical hallucination (i.e., the latter
referring to hallucinations in individuals who are in need of
professional help for these experiences) and consequently say
something about who needs treatment for their AVHs, and why.
Two main psychological mechanisms seem to be involved in this.
First, response to abnormal experience, such as AVHs, seems to
be cognitively mediated by beliefs or appraisals (Garety et al.,
2001). That is, the mere experience of AVHs itself might not
lead to full-blown psychotic hallucinations, but, for instance,
attributing the AVHs to an external malevolent source and giv-
ing it personal significance does. Another important determinant
of the transition to clinical states may be the level of func-
tional coping that the person mobilizes in the face of stressful
experiences such as AVHs. Active coping strategy such as using
problem-solving, seeking help, and distraction, seems to gen-
erate control over the experiences. In contrast, more passive
coping strategies such as going along with and indulging in the
content of hallucinations, isolating oneself, getting involved in
non-specific activities, do not generate more control over the
experiences.
Another way of clarifying the developmental trajectory of
AVHs involves the detailed assessment of changes in mental expe-
riences that occur before AVHs develop, especially during early
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(i.e., prodromal) phases of psychosis. A number of changes can
be observed that involve a general perceived change in the stream
of thoughts of the person (e.g., thoughts no longer shift smoothly
and effortlessly from one moment to the next). Individuals
may also report that thoughts feel anonymous or spatialized,
may acquire a quasi-sensorial concreteness or are experienced as
deprived of the tag of “mineness” and familiarity (cf. Larøi et al.,
2010; Raballo and Larøi, 2011).
THE CONTINUUM HYPOTHESIS
Another fruitful approach to help elucidate the emergence of
AVHs involves comparing AVHs present in persons with psy-
chosis compared with those AVHs experienced by non-clinical
persons or non-patients. As with the combined general pop-
ulation and longitudinal research described above, this line of
research provides ways of better differentiating between problem-
atic AVHs that call for treatment (e.g., that are associated with a
psychosis diagnosis), and those that do not.
Studies show that some 10–15% of the healthy population at
times experience AVHs (Sommer et al., 2010). In a recent review
of the literature (Beavan et al., 2011), which included 17 studies
that have examined the prevalence of AVHs in the adult gen-
eral population, the authors report prevalence rates ranging from
0.6 to 84%. The great majority of the studies included in this
review came from Western countries (European countries, the
USA) with the exception of two studies from New Zealand and
the Philippines. This high degree of variation in reports of AVHs
reflects differences in studies in terms of methodology and design
(definitions of hallucinations, how items are formulated, the con-
text of the study, participants’ socio-demographic characteristics,
etc.). For instance, high levels of AVHs prevalence are related
to definitions being too broad (e.g., “hearing vocal sounds” or
“hearing a voice saying a few words”), periods being too unspe-
cific (e.g., “have you ever experienced . . . ”), or the inclusion of
very common experiences (e.g., “heard own name in a shop”).
Moreover, in the few studies that investigated differences in the
frequency of hallucinatory experiences among different ethnic
groups, it was found that some ethnic groups are more likely than
others to report hallucinatory experiences. For example, higher
rates were reported for Brazilian, Russian, Caribbean, Hispanic,
and Black respondents compared to Western, Caucasian indi-
viduals. Other factors were also identified that play a role in
the variation of rates such as gender (higher in women) and
loss (e.g., decease of a loved one) and trauma (e.g., bullying,
sexual abuse).
Nevertheless, these types of findings suggest that hallucina-
tions in general, and AVHs in particular, may be considered as
dimensional phenomena lying on continua with normal expe-
riences (Johns and van Os, 2001), and that there are no clear
qualitative differences but rather quantitative differences between
normality and pathology. It is perhaps preferable to refer to this
as a continuum “hypothesis” or “view” (and not a model or
theory) as there is still debate concerning the true nature of
this continuum, and therefore, hopefully this debate will con-
tinue in years to come (David, 2011) as an uncritical accep-
tance of the continuum hypothesis is clearly to be avoided
(Badcock and Hugdahl, 2012).
In this context, it is also important to note that one can distin-
guish between at least two types of continua (Bentall, 2003; David,
2011):
(1) A continuum of experience, that is within an individual, and
which suggests that different kinds of experience (e.g., vivid
daydreams, intrusive, and vivid thoughts) may be related to
AVHs. This continuum may vary, for instance, from nor-
mal thoughts, to intrusive and vivid thoughts, to thoughts
resembling voices, and finally to AVHs.
(2) A continuum of risk, which is across several individuals, and
indicates that people differ in their proneness to have AVHs
experiences, and similarly also in their level of risk to develop
problematic or “clinical” AVHs. This continuum may vary,
for instance, in terms of frequency—from those with no
hallucination-proneness (e.g., that have never had an AVH
or AVH-like experience in their lives), to those who once or
sometimes have had such an experience, to those who have
it quite frequently, and finally to those who have it very fre-
quently. Similarly, persons on this continuum vary in terms
of risk: from those with no risk to develop clinical AVHs at
one extreme, to those with a very high risk to do so at the
other end.
Thanks to a significant body of studies that has appeared the
past few years, it is now possible to attempt to characterize those
persons (i.e., those 10–15% from the general population) who
lie on this continuum of risk. At the one end of the continuum
are those healthy individuals who experience AVHs very rarely,
perhaps often under specific conditions (such as after sleep depri-
vation or during severe stress), and where AVHs are not very
similar to those experienced by patients. Moving toward the other
end of the continuum one may plot those individuals who have
experienced AVHs from an early age, experience them relatively
frequently, that are quite similar to those observed in patients
with psychosis, are accompanied by subclinical levels of other
symptoms (e.g., paranoid delusions, paranormal beliefs, formal
thought disorder, depression, anxiety), and where there may also
be a family history of psychiatric illness.
What these individuals all have in common with each other is
that the experience of AVHs does not disturb their everyday life
functioning—nor does the fact of having AVHs prompt them to
seek professional help for these experiences. There is also a rela-
tively good level of insight regarding these experiences and they
do not fulfil criteria for a psychiatric or neurological disorder
(nor have they ever had one in the past). However, at least two
subgroups of non-patients along this continuum may be identi-
fied1. In one group, or non-patient type i, AVHs are not frequent
and are not very similar to AVHs in patients. On the other hand,
there are those, i.e., non-patient type ii, who experience AVHs
very frequently and these are very similar to those experienced
in patients. These two groups, moreover, probably plot somewhat
differently on the above-mentioned continua. Regarding the con-
tinuum of experience, non-patients i plot toward the left, whereas
1Please note that there is most definitely overlap between these two subgroups,
so they cannot be viewed as clearly distinct groups.
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non-patients ii plot very close to the right. Similarly, turning to
the continuum of risk, one may suggest that non-patients i plot
to the left, whereas non-patients ii are situated to the right of
the continuum. Also, this distinction will be important in the
present article as studies in the literature have included non-
patient groups of either type i or type ii. Important to underline
here is that individuals of type i non-patients may include those
based on vague and broad criteria mentioned earlier, and there-
fore AVHs experienced in this group of individuals are relatively
far-removed from those experienced by patients. Moreover, as
type ii non-patients experience AVHs that are closest to those
experienced by psychotic patient groups, studies including these
non-patient individuals will be emphasized as much as possible.
INCLUSION OF PATIENT VS. NON-PATIENT AVHs IN STUDIES
Studies that include non-patient groups in the context of AVHs
have either (1) only included non-clinical participants or (2) have
compared non-clinical and clinical participants in a direct man-
ner, that is, in the same study with the same methodology. Both
approaches have their merits, although it will be argued that the
latter study design is the preferred of the two.
Studies including only non-clinical participants are interest-
ing for a number of reasons. This study design allows one to
avoid confounding effects (e.g., on cognitive test performance
and neuroimaging data) associated with long-term medication
and institutionalization, illness duration, low level of education,
etc., present in patient populations. Also, studies that only include
non-clinical persons provide an examination (and eventual vali-
dation) of the various components of the continuum hypothe-
sis. These components may include, for example, distributional,
phenomenological, developmental, and etiological components
(Aleman and Larøi, 2008). The distributional component refers
to the fact that AVHs should be present not only in subjects iden-
tified as “clinical cases” but also in a proportion of subjects from
the general population that does not fulfil the clinical criteria of
a patient. The phenomenological component consists of reveal-
ing a sufficient degree of inter-group similarity, in addition to a
large degree of within-group variation, in terms of phenomeno-
logical characteristics of AVHs (e.g., degree of control, frequency,
duration, emotional response, and content). The developmental
component relates to aspects associated with the genesis of AVHs
and that they should also be continuous between pathological and
non-pathological samples. That is, factors identified as important
demographic risk factors in clinical cases of hallucinations (e.g.,
younger age, higher level of urbanicity, lower income, lower level
of education, unemployment, single marital status) should also
be associated with the presence of hallucinations in non-clinical
subjects. Finally, the etiological component maintains that clini-
cal and non-clinical populations should share common ground
in terms of underlying etiological mechanisms (e.g., cognitive,
psychological, and neural mechanisms) of AVHs.
In contrast, comparing non-patient with patient AVHs in the
same study has the vital advantage of being able to directly
compare, as it were, these two “types” of AVHs. Moreover, and
most importantly, such a study design is able to tease out both
similarities and differences between these two groups. Where
similarities are found, this points to mechanisms and factors that
are not involved in the emergence of problematic AVHs. In con-
trast, where differences are found between these two groups, this
indicates both possible factors andmechanisms involved in devel-
oping problematic AVHs, but also so-called “protective” mech-
anisms and factors that help prevent someone from developing
problematic AVHs. Thus, including clinical and non-clinical
individuals experiencing AVHs helps clarify which features of
AVHs do not do necessarily reflect pathology (e.g., in cases where
there are similarities between clinical and non-clinical groups)
and, on the other hand, those features that may reflect pathology
(e.g., in cases where the feature is present in clinical groups, but
not in non-clinical groups). Such an approach clearly has clini-
cal implications and will help identify new types of techniques to
add to the ever growing arsenal of intervention strategies available
for treating and managing hallucinations (cf. Larøi and Aleman,
2010).
What follows is a review of those studies that have done
just that—compared clinical and non-clinical AVHs in the same
study. Also, and for the reasons mentioned earlier, those studies
including non-patients of type ii will be given priority. Moreover,
these two types of AVHs will be compared in terms of their
phenomenology, cerebral correlates, and cognitive mechanisms.
Finally, emphasis will be made regarding eventual differences
between patient and non-patient AVHs and thus another impor-
tant characteristic of studies is that the study design allows for a
clear demarcation of similarities and differences between groups.
PHENOMENOLOGICAL STUDIES
The term “phenomenology” may be used in a number of different
ways. However, in this context it signifies the detailed description
of the clinical and/or descriptive features of signs and symptoms
observed in psychopathological conditions. In the case of AVHs,
this refers to evaluating such characteristics as frequency, con-
trollability, content, personification, emotional valence, duration,
localization, loudness, and number of voices.
INCLUSION OF A NON-PATIENT GROUP
Although the phenomenological characteristics of AVHs in
schizophrenia have been relatively well-described and studied in
the scientific literature, this is clearly not the case with AVHs
in non-patient populations. One exception is a recent and well-
designed study by Sommer et al. (2010), whereby a group of
non-clinical individuals experiencing AVHs is compared with a
group ofmatched healthy subjects. One of the particular strengths
of this study, and its study design, is the manner in which non-
clinical individuals are carefully recruited, and this according to
both strict and clear-cut criteria. A website providing informa-
tion about hearing voices was created with various questions,
including two items from the Launay–Slade Hallucinations Scale
(LSHS, Larøi et al., 2004: “In the past I have had the experience
of hearing a person’s voice and then found that there was no-
one there,” “I have been troubled by hearing voices in my head”).
Those with high scores on these two items were selected and were
interviewed by telephone to confirm that they met the following
criteria: (1) voices were distinct from thoughts and had a “hear-
ing” quality, (2) voices were experienced at least once a month,
(3) no diagnosis or treatment for psychiatric disorders other than
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depressive or anxiety disorders in remission, (4) no alcohol or
drug abuse for at least three months, (5) no chronic somatic
disorder, (6) 18 years of age or older, and (7) four Dutch-born
grandparents (to restrict heterogeneity for later genetic stud-
ies). This resulted in 103 individuals with AVHs and 60 control
participants. Control participants scored 0 on both LSHS items,
met the above-mentioned criteria, and were matched for sex, age,
and education.
Characteristics of hallucinations were assessed with the
Psychotic Symptom Rating Scales (PSYRATS; Haddock et al.,
1999) and the LSHS. Results for the AVH group showed that
the mean number of years experiencing AVHs was 29 years, and
the mean age at first experiencing voices was 14 years. The types
of voices experienced included commenting voices (18%) and
voices speaking with each other (11%). The majority (71%) never
heard AVHs with negative content only, 25% experienced both
positive and negative AVHs, and 4% experienced AVHs with a
negative content only. A great number (91%) reported no dis-
turbance of daily life by their AVHs. AVHs were attributed to an
external source in 58% of participants, mostly benevolent spirits.
Based on structured clinical interviews, they did not have clini-
cally relevant delusions, disorganization or negative or catatonic
symptoms and did not meet criteria for cluster A personal-
ity disorder. Global level of functioning (Global Assessment of
Functioning) was found to be lower than in the controls (82 and
87, respectively), although scores were within the normal range
and lower levels was predominately attributable to lower levels of
occupational functioning in the AVH group. There were signifi-
cantly higher scores on the Schizotypal Personality Questionnaire
(for both Total score and for scores on the Cognitive-perceptual,
Disorganzational, and Interpersonal sub factors) and the Peters
et al. Delusion Inventory (PDI), indicating a general increased
schizotypal and delusional tendency in the AVH group. History
of childhood trauma and family history of axis I disorders were
also significantly more prevalent in these individuals compared
to controls.
In summary, the AVH group experienced AVHs quite fre-
quently and from an early age, but did not fulfil criteria for any
clinical disorders. The AVHs they experience are both similar
to those in (psychotic) patient groups (e.g., commenting voices,
voices speaking with each other) but at the same time do not
resemble those experienced by patients in that they very rarely
have a negative content. The two groups did not differ consider-
ably in terms of global social functioning, but did differ in terms
of the presence of subclinical symptoms, history of childhood
trauma, and family history of axis I disorders. According to the
authors, these findings suggest that AVHs in otherwise healthy
individuals is not an isolated phenomenon but, rather, part of a
general vulnerability for schizophrenia. This might furthermore
suggest a genetic predisposition for schizophrenia in the AVH
group (e.g., based on a family history of axis I disorders), which,
however, is also in interaction with various environmental risk
factors (e.g., childhood trauma).
INCLUSION OF NON-PATIENT AND PATIENT GROUPS
As already mentioned, whilst studies only including non-patients
participants, such as the above-mentioned study, provide us with
important information concerning AVHs, the ideal study design
is to compare AVHs in patient and non-patient populations. At
present, only three studies (Leudar et al., 1997; Honig et al., 1999;
Daalman et al., 2011) have compared AVHs in non-patients with
patients suffering from psychosis.
The most recent study is Daalman et al. (2011). In this study,
non-patient individuals were recruited in the same manner as
described in Sommer et al. (2010). The non-patients (n = 111)
did not meet criteria for DSM-IV diagnosis, whilst the patient
group (n = 118) consisted of outpatients with a confirmed psy-
chotic disorder. Both groups experienced AVHs at least once a
month for over one year. The measure of AVHs included the
PSYRATS (Haddock et al., 1999), in addition to five supplemen-
tary questions assessing aspects not included in the PSYRATS
(e.g., age at onset, number of voices, personification, explanation
of origin).
Results revealed higher scores for patients for the follow-
ing AVH-related items of the PSYRATS: more negative content,
higher distress and disruption of daily life, greater frequency,
longer duration, and less controllability. Other phenomenolog-
ical characteristics, such as perceived location of voices (heard
inside or outside the head), loudness, number of voices, and
personification (attribution to a real and familiar person), did
not differ between the two groups. Interestingly, a very early
mean onset of AVHs was observed in non-patients (12 years of
age) and this was much lower than in patients (21 years). The
beliefs that individuals held about the origin of hallucinations also
differed. Non-patients frequently attributed their voices to spiri-
tual sources (spirits of deceased people, guardian angels, entities,
angels, presences), whereas patients often attributed their voices
to real people, such as the secret police, telepathic people, drug
gangs, or malevolent neighbors.
Previous studies of this kind have reported similar results.
For instance, Honig et al. (1999) compared non-patients with
two clinical groups (schizophrenia, dissociative disorders), all
of whom were experiencing AVHs. The non-patient group was
recruited via the local media, and included individuals with no
previous psychiatric history, no recent onset of another psychi-
atric disorder and a score on the Dissociative Experiences Scale
(Bernstein and Putnam, 1986) below 30. Hallucination assess-
ment was carried out by means of a semi-structured interview
with open-ended and closed questions relating to characteris-
tics of the hallucinations (e.g., frequency, number, form, content,
emotional qualities, gender, and age), history of the voices, cir-
cumstances related to the onset of hearing voices, present triggers,
personal interpretation of the voices, coping strategies, and life
history including traumatic experiences. Results revealed that
non-patients generally felt in control of the experience, in con-
trast to the two patient groups. All three groups reported positive
voices, but there were group differences in negative voices: these
were reported by all in the schizophrenia group, 93% in the disso-
ciative group, but only 53% in the non-patient group, suggesting
that negative voices differentiated the groups. Moreover, the two
patient groups were afraid of their voices, and reported significant
disturbances in their daily life, and that the voices were critical
and troublesome. A larger percentage of the non-clinical partici-
pants had an age of onset before 12 years of age (40%) compared
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to the dissociative (33%) and schizophrenia (11%) groups. In
terms of frequency, the daily and continuous experiences of voices
were more frequent in the patient groups than in the non-patient
group. Loci (AVHs experienced inside vs. outside the person)
were similar in all three groups.
Finally, based on structured interviews, Leudar et al. (1997)
examined specific pragmatic properties of AVHs (e.g., number
of voices, characteristics that individuate the voices, sequential
characteristics of the dialogs between voice hearers and their
voices, dialogical positioning of voices hearers, voices and other
individuals, and how the voices influence voice hearers’ activities)
and found no major differences in the structure and function of
the AVHs of these two groups (non-patients and patients with
schizophrenia both experiencing AVHs). However, they did note
that patients with schizophrenia were more likely to identify their
voices as being public figures, and that their voices were more
likely to instigate violence. The voices of the non-patients were
more likely to evaluate others, to have mundane content, and to
be identified as being the voices of family members.
Thus, on a phenomenological level, there appear to be both
similarities and differences between AVHs in patients and non-
patients. Concerning similarities, this seems to be related to more
perceptual and/or acoustic aspects such as such as localization,
loudness, number of voices, and personification. Differences seem
to be related to reactions to the voices and their effect on every-
day functioning, in particular the negative emotional content of
AVHs and the distress they elicit, in addition to higher frequency
and less control. One other important difference is the age of
onset of voices—around 12 years in non-patients compared to
21 in patients. As mentioned earlier, it is important to take into
account, and better understand, these differences as they provide
us with important clues as to why certain persons with these expe-
riences are able to function normally in everyday life, whilst others
(i.e., patients) are not.
NEUROIMAGING STUDIES
There has been an abundance of neuroimaging studies of AVHs
in schizophrenia the past few years (cf. reviews and meta-analyses
by Allen et al., 2008; Jardri et al., 2011; Kompus et al., 2011).
In general, a distributed brain network has been shown to be
implicated in the experience of AVHs. In their review of the lit-
erature, Allen et al. (2008) point to the involvement of secondary
(and sometimes primary) sensory cortices, prefrontal, subcorti-
cal, and cerebellar regions. Recently, Jardri et al. (2011) performed
a meta-analysis of studies (n = 10) examining cortical activation
(fMRI, PET) during AVHs and found that they were associ-
ated with increased activity in fronto-temporal (especially those
involved in speech generation and perception) and medial tem-
poral (hippocampal/parahippocampal regions) areas. In a highly
innovative recent study, Kompus et al. (2011) performed meta-
analyses of neuroimaging studies (fMRI, PET) examining patients
with schizophrenia (compared to healthy controls) during the
processing of auditory stimuli (11 studies), and studies includ-
ing patients experiencing AVHs in the absence of auditory stimuli
(12 studies). The results revealed increased activation in the left
primary auditory cortex and the right rostral prefrontal cortex
when experiencing AVHs (and in the absence of an external
stimulus) but, paradoxically, activation in these areas decreased
in the presence of auditory stimulation in patients when com-
pared with healthy controls. The authors suggest that this “para-
dox” is either caused by an attentional bias toward internally
generated information and/or the failure of a default network
to deactivate when auditory processing areas are engaged by
external stimuli.
Although much research has been devoted to examining cere-
bral correlates in patients experiencing AVHs, only one study has
compared patients and non-patients with AVHs (Diederen et al.,
in press). In this study, 21 non-psychotic subjects with AVHs and
21 matched patients with psychosis were asked to indicate the
presence of AVHs during functional magnetic resonance imag-
ing (fMRI). The non-patients were recruited in the same manner
as described in Sommer et al. (2010). The patients with psychosis
matched the non-patients for both demographic factors (e.g., age,
sex, handedness) and for the total duration of AVHs, the mean
duration of AVHs and the number of AVHs experienced during
fMRI scans. Furthermore, for all participants, the AVHs had to be
present with a frequency of at least four AVH episodes per scan,
had to last at least 50 s, and participants had to clearly indicate
both AVH onset and offset.
The results revealed that several areas were significantly acti-
vated during AVHs in both groups including the bilateral inferior
frontal gyri, insula, superior temporal gyri, supramarginal gyri
and postcentral gyri, left precental gyrus, inferior parietal lobule,
superior temporal pole and right cerebellum. The activation of
these areas duringAVHs is in linewith previous research including
patientswithpsychosiswithAVHs. Furthermore, and importantly,
no significant differences in activation during AVHs between the
groups were found. These findings suggest the involvement of the
same brain areas in non-patient and patient groups during AVHs.
COGNITIVE STUDIES
There has also beenmuch research examining the cognitive mech-
anisms involved in AVHs (cf. Aleman and Larøi, 2008). In general,
there seems to be a consensus that AVHs occur when a pri-
vate event is misattributed to a source that is external or alien
to the self. A two-step process is most probably implicated in
this (Larøi and Woodward, 2007) involving: (1) a form of auto-
noetic agnosia, or an inability to identify self-generated mental
events and then (2) amisattribution, whereby these self-generated
mental events are misattributed as coming from another (e.g., a
non-self, external, alien) source. A number of cognitive mech-
anisms that might underlie this process have been identified in
the literature and found to be associated with AVHs in patients
with psychosis. These include inhibition, source memory, contex-
tual memory, verbal self-monitoring, andmetacognitive beliefs. A
review of even a fragment of these studies is impossible in the con-
text of this article and, therefore, the interested reader may refer
to the many excellent reviews that exist on the topic (Seal et al.,
2004; Ditman and Kuperberg, 2005; Nieznan´ski, 2005; Aleman
and Larøi, 2008).
What interests us most here, though, is whether these pro-
posed cognitive mechanisms are also present in non-patient
groups experiencing AVHs. However, althoughmany studies have
examined the role of these cognitive mechanisms in both patient
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and non-patient groups, no study has done so in the same study2.
Furthermore, only some form of non-patient type i have been
included in these studies, unfortunately, leaving no study in the
literature examining the role of cognitive mechanisms in type ii
non-patients.
As an illustration, one proposed mechanisms involved in
AVHs, verbal self-monitoring, will be described in general and
in the context of studies of non-patients. One prominent model
(Frith, 1987, 1992) maintains that AVHs are the result of defective
self-monitoring, whereby defective monitoring of verbal thoughts
leads to a failure in the recognition of one’s own thoughts as
self-generated and, as a consequence, these thoughts are misiden-
tified as externally generated voices. A series of studies has tested
this hypothesis using a verbal self-monitoring task. This task
involves asking participants to pronounce a word, and then pro-
viding immediate auditory verbal feedback to participants via
earphones. This verbal feedback may be: (1) the participant’s
own voice fed back to the participant, (2) another person’s voice
(albeit of the same gender) fed back to the participant, (3) the
participant’s own voice fed back to the participant but where the
voice is distorted, or (4) another person’s voice (of the same gen-
der) fed back to the participant but where the voice is distorted.
Participants are then asked to say if the verbal feedback is their
own voice, someone else’s voice or not sure. In general, results
have found that patients with schizophrenia, and in particular
those with AVHs, make more errors than controls, and moreover
with a particular bias toward misattributing their own distorted
voice to another person. Important to note is that the evidence
that AVHs arise through a deficit in verbal self-monitoring alone
is equivocal (Allen et al., 2007) as, for instance, this finding has
not been found to be necessarily specific in patients with AVHs
and many times is also associated with other symptoms, such as
delusions.
Nevertheless, this line of research provides us with a good
example, as this same task has also been tested in various forms of
non-patient groups. In Johns et al. (2010), persons with At Risk
Mental State (ARMS)were comparedwith a group of healthy con-
trols on this task. The former group consisted of individuals who
experience attenuated forms of psychotic symptoms—symptoms
that are similar to full psychotic symptoms but less severe and
associated with greater insight. Results revealed impaired ver-
bal self-monitoring in the ARMS group compared to controls
(i.e., greater number of errors when own speech was distorted
and more likely to misattribute distorted own speech to another
source). Furthermore, the authors mention that the verbal self-
monitoring deficit seemed “to be less marked than in patients
with schizophrenia” although this could not be directly tested due
to the fact that a group of psychotic patients was not included in
the study. Allen et al. (2006) used a similar task, albeit in a group
of healthy individuals (University undergraduates) who com-
pleted scales measuring proneness toward hallucinations (LSHS)
and delusions (PDI, Peters et al., 1999). Results showed that mis-
attribution errors on the verbal self-monitoring task for own
2Kindly note that Badcock and Hugdahl (2012) have provided an excellent
review and discussion of possible patterns of shared and distinct cognitive
(and neural) AVH mechanisms in clinical and non-clinical populations.
distorted speech was significantly correlated to scores on the PDI
but that there was only a trend for a correlation with scores on the
LSHS. Finally, Versmissen et al. (2007) compared patients with
psychosis, and subjects from the general population with a high
level of psychotic experiences, on the verbal self-monitoring task.
The authors did not report significant differences between the
groups and, furthermore, mention that there were no abnormal
performances on the task.
Thus, in terms of cognitive studies—even amidst the multi-
tude of possible cognitive mechanisms implicated in AVHs based
on research with psychotic patients, studies have tested these
mechanisms in non-patient groups alone—but no study to date
has included both patient and non-patient groups. Furthermore,
at present, no study has included the all-important non-patient
type ii group. This results in it being highly difficult to suggest
which cognitive mechanisms are present in non-patient AVHs,
and impossible to say anything about which mechanisms are
involved (or not) in non-patient compared to patient AVHs.
Verbal self-monitoring studies were used to illustrate this.
CONCLUSIONS
In general, some studies have managed to tease out both sim-
ilarities and differences in patient and non-patient AVHs. The
greatest progress, however, is probably on a phenomenological
level. Here, it seems that differences between patients and non-
patients regards the reactions to AVHs and the effect AVHs have
on everyday life functioning. In contrast, in terms of cerebral
areas involved in patient vs. non-patient AVHs, there are far too
few studies examining this issue. The only existing study of this
kind did not observe any significant differences between cere-
bral activation in patient and non-patient AVHs. This finding is
interesting in itself, but evidently needs to be replicated in future
studies. Regarding cognitive mechanisms, unfortunately, there are
no studies that have directly compared clinical and non-clinical
AVHs and, therefore, it is difficult to determine whether or not
cognitive mechanisms (inhibition, source memory, verbal self-
monitoring, meta-cognitive beliefs) found to be present in patient
groups also play a role in AVHs in non-patient groups. Studies
that have included non-clinical participants (type ii) suggest that
the same cognitive mechanisms found to be involved in AVHs in
patients are also involved in non-patients. Whether they are to
the same extent as in patient groups, or whether deficit levels are
observed in these non-patient AVHs, however, is not known and
needs to be examined in future studies.
On a more general note, and as mentioned by Badcock and
Hugdahl (2012), there is a grave need for future studies to
more directly examine similarities and differences of patient and
non-patient AVHs on phenomenological, cognitive, cerebral (and
other) levels by including both types of individuals. It was men-
tioned that those non-patient studies examining, for instance,
cognitive mechanisms suggest that these same mechanisms are
implicated in both patient and non-patient AVHs. However, as
this has yet to be directly examined in studies, this can only
be characterized as being a tentative interpretation. Indeed, it is
possible that certain cognitive mechanisms are only implicated
in patient AVHs, yet to date studies have not been designed
to test this important hypothesis in a direct manner. We have
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perhaps (unknowingly) been too intent on identifying similarities
between patient and non-patient AVHs and at the same time have
not fully realized the significance of detecting differences between
these two. Consequently, future studies will also need to ensure
that study design will allow a clear demarcation of similarities
and differences between groups. Finally, the approach adopted
by Sommer and colleagues regarding recruitment of non-patient
individuals with AVHs is the best method as it allows for the
identification of non-patients of type ii, which are very close
on a number of levels to those AVHs experienced by patients
with psychosis. Hopefully other researchers will adopt a similar
recruitment method in forthcoming studies.
As a result of recent phenomenological studies, and in partic-
ular Daalman et al. (2011), two major differences seem to stand
out when comparing patient and non-patient AVHs, and there-
fore, merit further discussion: (1) the negative emotional content
of AVHs in patients and the distress they elicit, the higher fre-
quency, and less controllability, and (2) the lower age of onset of
AVHs in non-patients (12 years) compared to patients (21 years).
Negative content might explain both higher levels of distress and
frequency, and less control. That is, experiencing AVHs with a
highly negative content will render these experiences distressful
for individuals, leading to increased frequency and consequently
to less controllability due to a number of processes such as a
rebound effect. What remains to be explained is why patients’
AHVs are so negative. Studies have shown that childhood trauma
is present in non-patients experiencing AVHs (cf. Sommer et al.,
2010) and a growing body of research has similarly revealed that
patients with psychosis with AVHs have experienced early trauma
(cf. Fowler et al., 2006)3. Moreover, certain authors have convinc-
ingly argued that AVHs should be considered as a dissociative
experience and, in particular, as an after-effect of traumatic or
highly stressful experiences (cf. Moskowitz and Corstens, 2007).
This might also contribute to an understanding as to why non-
patient individuals who experience AVHs have such an early onset
(12 years of age), that is, in a period where such traumatic experi-
ences may have occurred. Escher et al. (2004) report that in their
cohort of 80 children and adolescents who experienced AVHs,
in about 75% of them, the onset of AVHs was related to trau-
matic events or circumstances beyond their control (e.g., death
of someone close, problems in the home situation or school, sex-
ual abuse, long-term physical illness, etc.). Another key to trying
to understand these findings may be related to emotion regu-
lation strategies. A study (van der Meer et al., 2009) using the
Emotion Regulation Questionnaire (ERQ; Gross and John, 2003)
has shown that patients with psychosis, compared to healthy
controls, tend to use suppression more often and reappraisal
strategies less often4. This pattern in relation to symptomatol-
ogy was not examined in this study, however, a recent study
(Badcock et al., 2011), also using the ERQ, found that, within
their group of patients with schizophrenia, an increased use of
3As this has not yet been done, it would be interesting for future studies to
directly compare patient and non-patient groups experiencing AVHs in terms
of early traumatic experiences (e.g., timing, frequency, type of events, etc.).
4Kindly note, however, that some studies have not replicated this finding
(cf. Henry et al., 2007, 2008).
suppression correlated positively with AVH severity (frequency,
duration, loudness). Thus, non-patients, in face of traumatic
and/or highly stressful situations develop AVHs as a dissocia-
tive reaction to these events but thanks to the increased use of
adaptive (e.g., reappraisal) and the decreased use of maladaptive
emotion regulation strategies (e.g., suppression), these individu-
als are able to adequately cope with the emotional force of these
experiences and, therefore, they will not have a major influence
on the content of the AVHs in these persons. In contrast, it may
be proposed that patients with psychosis who experience AVHs
who are also confronted with highly stressful or traumatic events
resulting in dissociative experiences such as AVHs, and that due
to the use of maladaptive emotion regulation strategies (and the
absence or less frequent use of more adaptive strategies)—these
individuals are not able to appropriately cope with the emotional
intensity of these experiences resulting in these experiences hav-
ing a profound influence on the content of their AVHs. Indeed,
the use of maladaptive emotion regulation strategies, such as sup-
pression, is related to a number of non-beneficial consequences
such as an inability to reduce the experience of unwanted emo-
tions. The precise mechanisms and processes involved in this (i.e.,
the dissemination of these strong emotions into the contents of
AVHs), however, are not known and, therefore, need to be directly
examined in future studies. Unfortunately, though, no study has
directly examined patients compared to non-patients with AVHs
regarding their use of emotional regulation strategies. However,
and as mentioned earlier, in order for future studies to maxi-
mize possibilities of identifying similarities—but most important
differences—between patient and non-patient groups with AVHs
(and furthermore due to the complex and multi-dimensional
nature of emotional regulation itself), it will probably be best to
include an extensive and multi-dimensional battery of emotion
regulation measures such as the Cognitive Emotion Regulation
Questionnaire (Garnefski et al., 2001) that includes a num-
ber of adaptive (e.g., acceptance, positive refocusing, refocus on
planning, positive reappraisal, putting into perspective) and mal-
adaptive (e.g., self-blame, rumination, catastrophizing, blaming
others) strategies, and not just the ERQ, which evaluates only sup-
pression and reappraisal. Furthermore, in order to properly test
this hypothesis, such investigations would have to take place early
in the individuals’ lives, such as in childhood. Another issue that
needs to be addressed is why patients develop their AVHs much
later (i.e., late adolescence/early adulthood) and not in childhood
when the majority of these traumatic events are likely to occur.
Finally, a number of other issues also need to be examined
in future studies. It was mentioned that combined epidemiologi-
cal and longitudinal studies have shown that the transition from
a non-clinical AVH to a clinical AVH is related to appraisals of
these experiences and how people cope with them. Concerning
the latter point, research presented in the present article sug-
gests that it may also be important to examine how people cope
with emotions in general (via emotion regulation strategies) and
not just how they cope with the AVHs themselves. Regarding
the former point, studies (cf. Birchwood and Chadwick, 1997)
show that much emotional (e.g., distress depression, anxiety)
and voice-driven behavior (e.g., maladaptive coping strategies)
in patients experiencing AVHs is mediated by the beliefs they
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have about the voice’s identify (e.g., a malevolent, omnipotent, or
omnipresent voice). For instance, voices believed to be malevo-
lent provoke fear and anger and are resisted, whereas benevolent
voices are associated with positive affect. It would be interesting
to examine the types of beliefs that non-patients have regard-
ing their voices. In this context, it is likely that non-patients do
not frequently hold beliefs that their voices are malevolent and
omnipotent, as Daalman et al. (2011) showed that non-patients
often attribute their voices to (benevolent) spiritual sources (such
as spirits of deceased people, guardian angels, entities, angels,
and presences) and furthermore that AVHs in non-patients rarely
provoke negative emotions such as distress and are rarely nega-
tive in content. Nevertheless, an examination of this issue merits
to be carried out. Similarly, it would be noteworthy to examine if
changes (described earlier in the article) in mental experiences—
such as changes in the stream of thought—occurring before
AVHs develop during prodromal phases in patients, also occur
in non-patients.
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